Results 51 to 60 of about 8,274 (166)
ObjectiveThis study aims to investigate clinical characteristics, potential risk factors, as well as long-term outcome in EGPA patients with GI involvement.MethodsA total of 94 EGPA patients were included in this cohort study. We retrospectively reviewed
Rongli Li +17 more
doaj +1 more source
This study aimed to assess diagnostic delay among patients with eosinophilic granulomatosis with polyangiitis (EGPA) and identify clinical characteristics associated with delayed recognition. EGPA diagnosis was delayed by nearly five years from symptom onset in this single‐center cohort.
Vani Mulkareddy +9 more
wiley +1 more source
Background An example of aggressive eosinophilic polyposis can be found in eosinophilic granulomatosis with polyangiitis (EGPA). Intercellular adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule-1 (vCAM-1) play a part in mediating the ...
Felicetti M +14 more
core +1 more source
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley +1 more source
Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterized by asthma, eosinophilia, and small vessel necrotizing granulomatosis with annual incidence of 0.5-4.2 cases per million.
Sagar Bishowkarma +7 more
doaj +1 more source
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo +4 more
wiley +1 more source
Serum biomarkers of patients with EGPA in remission and at relapse.
Data are shown as median (range in parenthesis); EGPA: eosinophilic granulomatosis with polyangiitis (Churg-Strauss); LR, Logistic regression analysis as described in Materials and Methods; MWU, Mann Whitney U test; n, number of visitsSerum biomarkers of
David Cuthbertson (188652) +14 more
core +1 more source
ABSTRACT This paper examines the interplay between agile digital transformation and the rule of law within the public sector, focusing on case studies from a semi‐large municipal government in the Netherlands and a department of the Flemish regional government in Belgium.
Shirley Kempeneer
wiley +1 more source
Introduction. Aortic involvement leading to aortitis in eosinophilic granulomatosis polyangiitis (EGPA) is infrequent, and only 2 cases have been reported so far in the literature. Even more so, aortic aneurysm, secondary to EGPA, has never been reported
Debendra Pattanaik +2 more
core +1 more source
ABSTRACT Over the past decade, the better regulation agenda has emerged as a powerful instrument for enhancing the law‐making process across the EU. This paper empirically investigates Greece's adherence to better regulation principles, focusing on key aspects such as the regulatory text, public consultation processes, impact assessments, parliamentary
Constantinos Saravakos +3 more
wiley +1 more source

